Multiple directors buying and Medicxi, page-17

Favourable Signals For Starpharma Holdings: Numerous Insiders Acquired Stock
https://**-st.cdn.ampproject.org/ii/AW/s/**.st/news/images/blue-bear.svg
Simply Wall St
Published July 04, 2024
https://**-st.cdn.ampproject.org/ii/AW/s/**.st/cdn-cgi/image/width=1200,height=411,fit=cover,format=auto/https://images.**.st/asset/industry/6121000-choice2-main-header/1585186699299
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Starpharma Holdings Limited (ASX:SPL), it sends a favourable message to the company's shareholders.

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares

Starpharma Holdings Insider Transactions Over The Last Year
In fact, the recent purchase by Jeff Davies was the biggest purchase of Starpharma Holdings shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of AU$0.096. Of course they may have changed their mind. But this suggests they are optimistic. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. In this case we're pleased to report that the insider purchases were made at close to current prices.

In the last twelve months Starpharma Holdings insiders were buying shares, but not selling